Ping An Biomedical Co., Ltd. (PASW)

Ping An Biomedical Cash Flow Statement

Financials in millions CNY. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Net Income	-12.83	-1.28	-0.99	7.23	5.21
Depreciation & Amortization	0.01	0.01	0.03	0.02	0.02
Other Adjustments	8.17	0.49	0.41	0.25	2.05
Change in Receivables	14.17	6.53	9.88	-7.79	-28.89
Changes in Inventories	-0.31	3.06	1.44	11.39	-10.18
Changes in Accounts Payable	-5.64	5.78	-8.76	10.9	5.19
Changes in Accrued Expenses	-0.32	-0.25	-0.93	1.5	-0.59
Changes in Income Taxes Payable	-0.33	0.33	-1.08	0.44	-0.25
Changes in Unearned Revenue	-1.6	1.14	0.26	-1.4	-1.08
Changes in Other Operating Activities	-7.73	-1.17	-6.33	-1.45	-5.01
Operating Cash Flow	-6.43	14.63	-6.08	21.09	-31.37
Capital Expenditures	-	-	-	-0.02	-0.03
Other Investing Activities	-	15	-3.37	-30.23	-
Investing Cash Flow	-	15	-3.37	-30.26	-0.03
Short-Term Debt Issued	10	15.6	42.5	48.86	28.5
Short-Term Debt Repaid	-10	-48.1	-35.5	-41.85	-22
Net Short-Term Debt Issued (Repaid)	0	-32.5	7	7	6.5
Issuance of Common Stock	108.19	-	-	0.01	-
Net Common Stock Issued (Repurchased)	108.19	-	-	0.01	-
Common Dividends Paid	-	-0.32	-9.6	-4.83	-
Other Financing Activities	-64.53	2.73	11.48	8.06	24.95
Financing Cash Flow	43.66	-30.09	8.87	10.24	31.45
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0.67	-0	0	-0.01	-0.1
Net Cash Flow	37.23	-0.46	-0.58	1.07	0.05
Free Cash Flow	-6.43	14.63	-6.08	21.06	-31.4
FCF Margin	-18.82%	16.70%	-7.37%	18.39%	-31.55%
Free Cash Flow Per Share	-0.35	0.81	-0.34	1.17	-1.74
Levered Free Cash Flow	-28.76	-24.89	-9.37	35.61	-0.22
Unlevered Free Cash Flow	-28.78	8.89	-29.97	29.5	-6.42

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.